Bio-Matrix Signs Letter of Intent with Vibragene | GenomeWeb
NEW YORK (GenomeWeb News) – Bio-Matrix Scientific Group has signed a letter of intent with the genetic analysis and anti-aging specialty company Vibragene, under which it will negotiate an agreement to supply genetic testing for certain disease biomarkers.
 
Bio-Matrix said that Vibragene expects to send it 100,000 specimens during the next 12 months. The firm also said that the addition of the DNA testing capabilities complements its current business lines of processing and storing stem cells for future medical use.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Arizona is planning to sue Theranos for "deceptive acts" and misrepresentations of its "capabilities and operation."

If confirmed as Department of Health and Human Services Secretary, Tom Price says he will divest himself of certain holdings, according to Stat News.

Oliver Smithies, who won the Nobel Prize in 2007, has died, the New York Times reports.